Trial intelligence / Profile preview

CMR of Doxorubicin-Induced Cardiac Remodeling in Breast Cancer

NCT03000036Completed

Sponsor
Universidade Estadual de Campinas
Start
Jul 2012
Primary completion
Jan 2015
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Universidade Estadual de Campinas. Primary endpoints: Quantification of fibrosis index by Cardiac Magnetic Resonance at 2 years and Intracellular lifetime of water (τic) by Cardiac Magnetic Resonance at 2 years. Started Jul 2012; status: completed.

Beyond the preview

Go deeper on NCT03000036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03000036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call